COVID-19 Updates
From the Journals
Untreated COVID often involves relapse, clarifying antiviral rebound discussion
A new study’s findings offer a natural history of COVID-19 that will inform discussions and research concerning anti-viral therapy.
Commentary
What’s new in brain health?
A new study shows that nonmedical treatment is effective in people with frequent episodic and chronic tension-type headache.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
From the Journals
Cardiac issues twice as likely with COVID plus high troponin
Hospitalized COVID-19 patients with high troponin levels were twice as likely to have cardiac abnormalities due to diverse causes in a large U.K....
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
From the Journals
Prehospital COVID therapy effective in rheumatic disease patients
Patients with rheumatic disease and SARS-CoV-2 infection who received outpatient treatment fared better than similar patients who did not receive...
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
Commentary
The five biggest changes in the 2023 adult vaccine schedules
COVID vaccines are now front and center among 2023’s five most important changes.
Latest News
AAP approves 2023 child and adolescent immunization schedule
The updated recommendations do not include major changes from those released in 2022 by the Advisory Committee on Immunization Practices, except...
Commentary
A new (old) drug joins the COVID fray, and guess what? It works
Part of the reason the monoclonals have failed lately is because of their specificity.